Immunoact Announces Partnership with Mango Sciences to Bring the World’s First Bridge Financing Plan and Value-Based Offering For CAR-T Therapy for Cancer Patients in India
New Delhi [India], December 2: Partnership enables ImmunoACT to offer eligible patients a bridge financing plan and value-based offering to access its NexCAR19TM CAR-T therapy for leukaemia and lymphoma. Mumbai, India, December 2: ImmunoAdoptive Cell Therapy (ImmunoACT), the Mumbai, India-based pioneering research and cell and gene therapy development company, announced a strategic partnership with Mango Sciences, […]
Continue Reading